Related Experiment Videos
4-Phenyl-4H-pyrans as IK(Ca) channel blockers
Klaus Urbahns1, Ervin Horváth, Johannes Peter Stasch
1Institute of Medicinal Chemistry, Pharma Research Center, Bayer AG, D-42096, Wuppertal, Germany. klaus.urbahns.ku1@bayer.co.jp
Bioorganic & Medicinal Chemistry Letters
|July 23, 2003
Summary
New 4-Phenyl-4H-pyrans effectively block intermediate-conductance calcium-activated potassium channels (IK(Ca)). A specific derivative, rac-11, demonstrated significant reduction in brain injury after traumatic brain injury in rats.
Area of Science:
- Medicinal Chemistry
- Neuropharmacology
- Ion Channel Modulation
Background:
- Intermediate-conductance calcium-activated potassium channels (IK(Ca)) play a role in neuronal function and injury.
- Developing specific modulators of IK(Ca) channels is crucial for therapeutic interventions.
Purpose of the Study:
- To synthesize and characterize novel 4-Phenyl-4H-pyran derivatives as IK(Ca) channel blockers.
- To evaluate the therapeutic potential of these compounds in a preclinical model of traumatic brain injury.
Main Methods:
- Synthesis of a library of 4-Phenyl-4H-pyran compounds.
- Structure-activity relationship analysis of synthesized derivatives.
- In vivo testing of a selected compound (rac-11) in a rat subdural hematoma model.
Main Results:
- 4-Phenyl-4H-pyrans were identified as potent and specific IK(Ca) channel blockers.
- Structure-activity relationships guided the selection of promising candidates.
- Intravenous administration of rac-11 significantly reduced infarct volume in the traumatic brain injury model.
Conclusions:
- 4-Phenyl-4H-pyrans represent a promising class of IK(Ca) channel blockers.
- The derivative rac-11 shows therapeutic potential for treating traumatic brain injury.